Derynck Mika K bought ELVN
August 4, 2026 · Form 4 insider transaction
Derynck Mika K bought 20,491 shares of Enliven Therapeutics, Inc. at $22.47 per share, a transaction worth $460.4K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
20,491
Price
$22.47
Total value
$460.4K
InsiderDerynck Mika K
RoleDirector
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateAugust 4, 2026
Filing dateAugust 6, 2026
Shares owned after158,795
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 8, 2025.